Fmoc-L-MeGlu(tBu)-OH

Fmoc-L-MeGlu(tBu)-OH is an Fmoc-protected, side-chain modified glutamic acid derivative in which the α-amino group is masked by the fluorenylmethoxycarbonyl (Fmoc) protecting group and the side-chain carboxyl functionality is present as a tert-butyl ester (tBu). The molecule retains the L-stereochemical configuration at the glutamate α-carbon, providing a defined chiral center for stereocontrolled peptide assembly. The combination of an acid-labile tBu ester and base-labile Fmoc carbamate enables orthogonal deprotection logic that is compatible with standard solid-phase peptide synthesis and subsequent functional group unveiling. The resulting protected amino acid building block bears a free side-chain carboxyl after tBu removal and a protected backbone amine, supporting downstream derivatization, coupling chemistry, and conversion into peptide-bound glutamate motifs or glutamate-based intermediates.

1. Peptide Synthesis

Fmoc-L-MeGlu(tBu)-OH supports peptide building block preparation for automated and manual peptide synthesis workflows where orthogonal protection is required. The Fmoc group enables controlled N-terminal protection during chain elongation, while the tBu ester on the side-chain carboxyl helps prevent undesired side reactions during peptide coupling cycles. The glutamate side-chain topology and stereodefined L-configuration facilitate incorporation into peptide sequences that require a carboxylate-functional residue for salt-bridge formation, metal coordination, or hydrogen-bonding patterns. After selective deprotection, the side-chain carboxyl can be used for further peptide modification or for generating glutamate-bearing analogs used in biochemical research and peptide-scaffold refinement. Fmoc-L-MeGlu(tBu)-OH therefore functions as a practical protected glutamate derivative for constructing peptide frameworks with controlled functional group presentation.

2. Amino Acid Derivatization

Fmoc-L-MeGlu(tBu)-OH can be applied in amino acid derivatization chemistry to generate protected glutamate intermediates for downstream functional transformations. The protected amine (Fmoc carbamate) and esterified side-chain carboxyl (tBu ester) provide chemical handles that can be selectively unmasked to trigger coupling, activation, or conjugation steps without premature cross-reactivity. The side-chain carboxyl, once deprotected, can be converted into amides, esters, or activated carboxylic acid derivatives suitable for building peptide-like structures, chelating motifs, or linker units for molecular conjugates. The defined stereochemistry at the α-carbon supports consistent reactivity and predictable incorporation into stereochemically constrained products. This makes the compound suitable for preparing functionalized amino acid derivatives used as synthetic intermediates in fine chemical synthesis and applied research.

3. Bioconjugation Chemistry

Fmoc-L-MeGlu(tBu)-OH enables bioconjugation-oriented linker and scaffold construction where a glutamate-derived carboxyl group is required for controlled attachment chemistry. The orthogonality between Fmoc deprotection and tBu ester removal supports stepwise unveiling of the amine and side-chain carboxyl functionality, enabling sequential coupling strategies to biomolecule-reactive intermediates. The glutamate side chain offers a negatively charged carboxylate equivalent after deprotection, which can be used to tune spacing, solubility, and electrostatic interactions in conjugates. Incorporation into peptide tags or peptide-based linkers can then support labeling workflows for chemical biology studies, including preparation of glutamate-containing conjugation handles for downstream attachment to proteins, peptides, or other biomolecular carriers. The compound's protected functional groups align with peptide-compatible conjugation design and synthetic intermediate preparation for applied biomolecule modification.

4. Process Chemistry Intermediate

Fmoc-L-MeGlu(tBu)-OH is suitable as a chiral, protected amino acid intermediate for process chemistry and specialty chemical production routes that require reliable orthogonal protection behavior. The Fmoc carbamate and tert-butyl ester provide protecting-group stability during coupling and purification operations, while enabling predictable deprotection sequences when converting to reactive glutamate forms. The stereodefined L-glutamate backbone supports consistent downstream transformations into glutamate-containing intermediates used for peptide analog manufacturing and process-scale fine chemical synthesis. The presence of protected amine and protected side-chain carboxyl reduces side reactions such as uncontrolled amide formation or carboxylate-mediated coupling during intermediate handling, which can be relevant for scalable manufacturing design. Fmoc-L-MeGlu(tBu)-OH therefore serves as a process-compatible building block for producing protected glutamate derivatives and peptide synthesis inputs in industrial settings.

5. Pharmaceutical Intermediate Synthesis

Fmoc-L-MeGlu(tBu)-OH can be employed in pharmaceutical intermediate synthesis for constructing glutamate-motif fragments used in peptidomimetics and peptide-like drug discovery programs. The amino acid architecture provides a stereodefined chiral center and a carboxyl-functional side chain that can be unmasked to generate activated carboxylic acid derivatives or to form amide-linked pharmacophore elements. The Fmoc-protected N-terminus supports peptide coupling compatibility, enabling incorporation into longer sequences or structured fragments that require controlled functional group exposure. The tBu ester protection strategy helps regulate side-chain reactivity during synthesis, supporting downstream formation of specific substitution patterns on the glutamate side chain. This positions Fmoc-L-MeGlu(tBu)-OH as a useful protected amino acid derivative for generating intermediates that feed into medicinal chemistry and applied scaffold construction.

1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

2. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

3. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

4. Cationic cell-penetrating peptides are potent furin inhibitors

5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die